Pharming Group N.V. Sponsored ADR (PHAR) closed the last trading session at $12.66, gaining 24.2% over the past four weeks, ...

Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ultra-high dividend make it a good choice for long-term investors.

Trading app expands its AI assistant with “Digests”, offering investors plain-English explanations of stock price movements.

Options put-call ratios and implied volatility are two factors that may be able to lend some guidance as to future stock price movements. First, let's just look at the simple chart for Nvidia (NVDA).

Their bulk investment action then leads to price movement for the stock. Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for LATAM imply an improvement in the ...

Image source: The Motley Fool. There has been no correlation between Oxy beating, meeting, or missing its earnings-per-share (EPS) estimates and its next-day (or even week) stock price movements.

ACNB (ACNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ultra-high dividend make it a good choice for long-term investors.